Adenoid Cystic Carcinoma
📧 Sign up to get email alerts when something new happens for Adenoid Cystic Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck [Phase 2]
Phase II trial evaluating doxorubicin and bortezomib in patients with incurable adenoid cystic carcinoma of the head and neck has completed.…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating sunitinib for recurrent and/or metastatic adenoid cystic carcinoma of the sa…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Study of RAD001 in Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 study of RAD001 (everolimus) for Adenoid Cystic Carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors [Phase 2]
A Phase 2 trial evaluating dasatinib for recurrent or metastatic malignant salivary gland tumors has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Dovitinib in Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating dovitinib in Adenoid Cystic Carcinoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer [NA]
The clinical trial evaluating transoral robotic surgery for benign or Stage I-IV head and neck cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck [Phase 2]
This Phase 2 trial update examines bortezomib followed by doxorubicin at progression in patients with locally advanced, recurrent, or metast…